Mode
Text Size
Log in / Sign up

Medically supervised ketogenic diet shows preliminary efficacy for moderate to severe major depressive disorder in a pilot trialKetogenic Diet May Ease Severe Depression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider MSKD as a potential intervention for MDD, but await larger RCTs before adoption.

This open-label, single-arm pilot feasibility trial assessed the safety, tolerability, and preliminary clinical efficacy of a medically supervised ketogenic diet (MSKD) in individuals with moderate to severe major depressive disorder. Eleven participants were virtually enrolled through Kingston General Hospital in Ontario, Canada, with eight completing the 14-week intervention. The primary outcomes focused on feasibility, safety, and symptom changes, while secondary outcomes included adherence and retention rates. Follow-up assessments occurred at 3.2 months.

Participants experienced mild and transient side effects primarily during the induction phase, with no serious adverse events or dropouts reported during the maintenance phase. The study demonstrated robust feasibility, safety, and tolerability for the MSKD protocol. Clinically significant reductions in depressive symptoms were observed, with a mean effect size of 23.33 points on the MADRS scale (95% CI: 17.95-28.71; p < 0.001). Anxiety symptoms (GAD-7) showed a mean reduction of 8.8 points (p = 0.005), and anhedonia (SHAPS) decreased by a mean of 4.8 points (p = 0.001). Additionally, 87.5% of participants achieved remission.

Key limitations include the open-label, single-arm design, small sample size, and the pilot nature of the study, which preclude definitive causal conclusions. Funding sources and conflicts of interest were not reported. These preliminary findings suggest potential benefits but require validation in larger, randomized controlled trials before clinical recommendations can be made.

Imagine feeling heavy and hopeless, unable to find joy in things you used to love. Now imagine a simple change in what you eat helping lift that weight.

A new study suggests that a specific diet could be a powerful tool for fighting depression.

Major Depressive Disorder is common. It often comes with other health problems like diabetes or heart issues. Many people try different medicines or talk therapy. But for some, these options do not work well enough.

Doctors are looking for new ways to help. This study looks at the ketogenic diet. This is a low-carb, high-fat eating plan. It forces your body to burn fat for fuel instead of sugar.

The surprising shift

For a long time, doctors thought food was just fuel. We did not think it could treat mental health. But research is changing that view.

But here's the twist. This study did not just ask if people felt better. It also checked if the diet was safe and easy to do.

What scientists didn't expect

The researchers used a simple analogy to explain how this might work. Think of your brain cells like a busy city. Too much sugar traffic causes jams and stress.

The ketogenic diet acts like a traffic cop. It clears the roads so your brain can function smoothly again. This might help calm the brain's overactive signals that cause sadness and worry.

The team ran a 14-week trial in Ontario, Canada. They worked with 11 people who had moderate to severe depression.

Everyone followed a medically supervised plan. They started with a two-week introduction period. Then they continued for 12 more weeks with a dietitian's help.

The results were very promising. Most participants stayed on the diet without quitting. Only mild side effects happened, mostly at the start.

Depression scores dropped significantly. In plain English, people felt much less sad. Anxiety also went down. Even the feeling of being unable to feel pleasure improved.

This doesn't mean this treatment is available yet.

The catch

There is a big reason to be careful. Only 11 people joined the study. That is a very small group.

Because the group was so small, we cannot say this works for everyone. We also do not know if it works for everyone with depression.

Experts say this is a good first step. It shows the diet is safe to try under medical supervision.

However, they agree we need bigger studies. Large trials will tell us if this is a standard treatment option. Until then, it remains an experimental approach.

If you have depression, talk to your doctor first. Do not stop your current medicine without advice.

This diet requires strict planning and monitoring. You need a professional to guide you. It is not a quick fix you can try alone.

More research is needed. Scientists plan larger trials to confirm these results. They will test if this works for different types of depression.

We are moving closer to new options for mental health. But patience is key. Good science takes time to prove itself.

Study Details

EvidenceLevel 5
Follow-up3.2 mo
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: Major Depressive Disorder (MDD) is a prevalent psychiatric condition frequently associated with metabolic dysfunction. Metabolic interventions, including the ketogenic diet (KD), have shown potential antidepressant effects; however, rigorous clinical evaluation remains limited. This pilot study aimed to assess the feasibility, safety, tolerability, and preliminary clinical efficacy of a medically supervised ketogenic diet (MSKD) in individuals with moderate to severe depression. METHODS: An open-label, single-arm, 14-week pilot feasibility trial was conducted virtually through Kingston General Hospital, Ontario, Canada. Participants underwent a two-week KD induction phase, followed by a 12-week follow-up phase under the supervision of a registered dietitian. Feasibility outcomes included adherence (sustained nutritional ketosis defined by blood ketones ≥0.5 mmol/L), tolerability, recruitment, and retention rates. Clinical outcomes were assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS), Generalized Anxiety Disorder-7 scale (GAD-7), and Snaith-Hamilton Pleasure Scale (SHAPS). RESULTS: From an initial 89 interested individuals, 11 (12.4 %) participants were enrolled and began the intervention. Of these, 8 (72.7 %) successfully completed both induction and maintenance phases, all maintaining nutritional ketosis. Adherence was high, with no dropouts during the maintenance phase. Mild and transient side effects were reported primarily during induction. Clinically significant reductions were observed in depressive symptoms (change from the baseline MADRS score estimate from the model was 23.33 points, 95 % CI: 17.95-28.71; p < 0.001). remission in 87.5 %), anxiety symptoms (GAD-7 mean reduction of 8.8 points, p = 0.005), and anhedonia (SHAPS mean reduction of 4.8 points, p = 0.001). DISCUSSION: This pilot study demonstrated robust feasibility, safety, and tolerability of a medically supervised ketogenic diet in individuals with moderate to severe depression. Preliminary findings indicate significant improvements in depressive symptoms, anxiety, and anhedonia, supporting further investigation in larger, randomized controlled trials. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT05558995.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.